Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts

por Lee, Woan-Ruoh, Shen, Shing-Chuan, Shih, Yi-Hsien, Chou, Chia-Lun, Tseng, Jonathan Te-Peng, Chin, Szu-Ying, Liu, Kao-Hui, Chen, Yen-Chou, Jiang, Ming-Chung
Publicado 2015